A double-blind, placebo-controlled, dose-escalation trial of pimavanserin in Parkinson's disease and psychosis

被引：0
|
作者：
Revell, Stephen
Friedman, Joseph
Mills, Roger G.
Williams, Hilde
Johnson, Ann D.
Bahr, Daun
机构：
来源：
NEUROLOGY | 2008年 / 70卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A284 / A285
页数：2
相关论文
共 50 条
  • [21] Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study
    Tehranchi, Ramin
    Pettersson, Jonas
    Melgaard, Anita E.
    Seitz, Friedeborg
    Valeur, Anders
    Maarbjerg, Stine Just
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2022, 96
  • [22] Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trial
    Nomoto, Masahiro
    Mizuno, Yoshikuni
    Kondo, Tomoyoshi
    Hasegawa, Kazuko
    Murata, Miho
    Takeuchi, Masahiro
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    JOURNAL OF NEUROLOGY, 2014, 261 (10) : 1887 - 1893
  • [23] Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
    Masahiro Nomoto
    Yoshikuni Mizuno
    Tomoyoshi Kondo
    Kazuko Hasegawa
    Miho Murata
    Masahiro Takeuchi
    Junji Ikeda
    Takayuki Tomida
    Nobutaka Hattori
    Journal of Neurology, 2014, 261 : 1887 - 1893
  • [24] A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease
    Payne, Thomas
    Appleby, Matthew
    Buckley, Ellen
    van Gelder, Linda M. A.
    Mullish, Benjamin H. H.
    Sassani, Matilde
    Dunning, Mark J. J.
    Hernandez, Dena
    Scholz, Sonja W. W.
    McNeill, Alisdair
    Libri, Vincenzo
    Moll, Sarah
    Marchesi, Julian R. R.
    Taylor, Rosie
    Su, Li
    Mazza, Claudia
    Jenkins, Thomas M. M.
    Foltynie, Thomas
    Bandmann, Oliver
    MOVEMENT DISORDERS, 2023, 38 (08) : 1493 - 1502
  • [25] A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease
    Damier, Philippe
    Degos, Bertrand
    Castelonovo, Giovanni
    Anheim, Mathieu
    Benatru, Isabelle
    Carriere, Nicolas
    Colin, Olivier
    Defebvre, Luc
    Deverdal, Marie
    Eusebio, Alexandre
    Ferrier, Vanessa
    Giordana, Caroline
    Houeto, Jean-Luc
    Le Dily, Severine
    Mongin, Marie
    Thiriez, Claire
    Tranchant, Christine
    Ravel, Denis
    Corvol, Jean-Christophe
    Rascol, Olivier
    Ben Ari, Yehezkel
    MOVEMENT DISORDERS, 2024, 39 (03) : 618 - 622
  • [26] A double-blind, placebo-controlled trial of donepezil in patients with Parkinson's Disease and related dementia
    Brashear, A
    Kuhn, ER
    Lane, KA
    Farlow, MR
    Unverzagt, FW
    NEUROLOGY, 2004, 62 (07) : A524 - A525
  • [27] A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease
    Ondo, WG
    Hunter, C
    Moore, W
    NEUROLOGY, 2004, 62 (01) : 37 - 40
  • [28] Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    Athauda, Dilan
    Maclagan, Kate
    Skene, Simon S.
    Bajwa-Joseph, Martha
    Letchford, Dawn
    Chowdhury, Kashfia
    Hibbert, Steve
    Budnik, Natalia
    Zampedri, Luca
    Dickson, John
    Li, Yazhou
    Aviles-Olmos, Iciar
    Warner, Thomas T.
    Limousin, Patricia
    Lees, Andrew J.
    Greig, Nigel H.
    Tebbs, Susan
    Foltynie, Thomas
    LANCET, 2017, 390 (10103): : 1664 - 1675
  • [29] Liraglutide once daily versus placebo in Parkinson's disease: a randomized, double-blind, placebo-controlled trial
    Wu, T.
    Bresee, C.
    Wertheimer, J.
    Hogg, E.
    Malatt, C.
    Tan, E.
    Pomeroy, H.
    Obialisi, G.
    Tagliati, M.
    MOVEMENT DISORDERS, 2022, 37 : S359 - S360
  • [30] A double-blind, placebo-controlled single dose trial of intravenous flumazenil in Alzheimer's disease
    Templeton, L
    Barker, A
    Wesnes, K
    Wilkinson, D
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1999, 14 (04) : 239 - 245
12345